Stay updated on SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial

Sign up to get notified when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-31T15:34:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to the term “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), and directs visitors to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T17:31:45.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-17T17:08:08.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T18:04:28.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    New revision entry v3.7.0 has been added to the study record history, and the previous revision v3.6.6 has been removed from the history.
    Difference
    0.1%
    Check dated 2026-09-19T19:18:14.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the record history and the previous entry v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-08-29T18:53:02.000Z thumbnail image

Stay in the know with updates to SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SGLT-2 Inhibitor in HF Hepato-Renal Clinical Trial page.